Further funding announced for clinical studies and data investigation
After a year of disruption, clinical research has now restarted and lab-based research is getting back on track. Cure Parkinson’s is delighted to report that it is investing significant funds into research in the first quarter of 2021.
Learn more
Farnesol: from perfume to Parkinson’s
A ground-breaking Cure Parkinson’s supported study that involved screening over 230,000 molecules has identified farnesol, a commonly found aromatic oil, as a new potential treatment of Parkinson’s.
The Henley Mermaids take on the Bristol Channel
On 20 July, Laura Reineke, Jo Robb, Fiona Print, Susan Barry and Joan Fennelly, otherwise known as the Henley Mermaids, swam 61km across the Bristol Channel in support of Cure Parkinson’s and three other charities dedicated to neurological conditions. The Henley Mermaids are a group…
Daisy Doyle plants 50 oak trees for Parkinson’s research
Last Autumn, 11 year old Daisy Doyle, granddaughter of Cure Parkinson’s co-founder Air Vice Marshal Michael Dicken and Patron Jenny Dicken, planted 50 oak trees on her family farm in Umberleigh, Devon in support of our research into a cure for Parkinson’s. Daisy chose to…
Cure Parkinson’s Raid Local 2021
On Sunday 27 June over 300 Cure Parkinson’s supporters from across the world jumped in the saddle to take on the charity’s Raid Local 2021: Ventoux! cycling challenge, raising awareness and over £53,000 for Parkinson’s research.
Encouraging trial results from Anavex
Recent positive results from biotech company Anavex Life Sciences have shown that when treated with their experimental drug, blarcamesine, individuals with Parkinson’s dementia had significant improvements in both motor and cognitive symptoms.